James Mahon

786 total citations
33 papers, 568 citations indexed

About

James Mahon is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, James Mahon has authored 33 papers receiving a total of 568 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Oncology and 5 papers in Epidemiology. Recurrent topics in James Mahon's work include Diabetes Management and Research (4 papers), Diabetes Treatment and Management (3 papers) and Child Nutrition and Feeding Issues (2 papers). James Mahon is often cited by papers focused on Diabetes Management and Research (4 papers), Diabetes Treatment and Management (3 papers) and Child Nutrition and Feeding Issues (2 papers). James Mahon collaborates with scholars based in United Kingdom, United States and Netherlands. James Mahon's co-authors include Angela Boland, Y Dündar, Sophie Beale, Nick Hex, Eleanor Kotas, Chris Bartlett, Yevgeniy Samyshkin, Mike Baxter, Nigel Fleeman and Julie Glanville and has published in prestigious journals such as PLoS ONE, BMJ Open and Health Technology Assessment.

In The Last Decade

James Mahon

28 papers receiving 545 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
James Mahon United Kingdom	14	123	109	72	57	56	33	568
Arthur Isnani Saudi Arabia	12	55 0.4×	135 1.2×	104 1.4×	73 1.3×	67 1.2×	34	505
Ravinder Mohan Pandey India	16	85 0.7×	121 1.1×	142 2.0×	163 2.9×	76 1.4×	33	727
Sumedh S. Hoskote United States	12	129 1.0×	52 0.5×	99 1.4×	88 1.5×	47 0.8×	42	491
Francesco Venturelli Italy	14	42 0.3×	66 0.6×	152 2.1×	63 1.1×	80 1.4×	52	667
D.S. Chadha India	11	107 0.9×	128 1.2×	149 2.1×	89 1.6×	81 1.4×	43	561
Philip R. Orlander United States	14	56 0.5×	188 1.7×	51 0.7×	105 1.8×	136 2.4×	23	725
Sasson Nakar Israel	15	59 0.5×	161 1.5×	130 1.8×	85 1.5×	201 3.6×	44	748
Muhammad Haisum Maqsood United States	13	42 0.3×	39 0.4×	137 1.9×	92 1.6×	54 1.0×	76	544
Ramón Castillo United States	13	135 1.1×	31 0.3×	66 0.9×	131 2.3×	57 1.0×	31	681
Ofer Kobo Israel	14	64 0.5×	88 0.8×	99 1.4×	102 1.8×	102 1.8×	83	621

Countries citing papers authored by James Mahon

Since Specialization

Citations

This map shows the geographic impact of James Mahon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Mahon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Mahon more than expected).

Fields of papers citing papers by James Mahon

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Mahon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Mahon. The network helps show where James Mahon may publish in the future.

Co-authorship network of co-authors of James Mahon

This figure shows the co-authorship network connecting the top 25 collaborators of James Mahon. A scholar is included among the top collaborators of James Mahon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Mahon. James Mahon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Taylor, Matthew, et al.. (2025). Clinical equivalence and non-inferiority within health technology assessment. The European Journal of Health Economics. 27(1). 29–45. 1 indexed citations

Fleeman, Nigel, Rachel Houten, Sarah J Nevitt, et al.. (2024). Lenvatinib plus pembrolizumab for untreated advanced renal cell carcinoma: a systematic review and cost-effectiveness analysis. Health Technology Assessment. 28(49). 1–190.

Houten, Rachel, Nigel Fleeman, James Mahon, et al.. (2023). Trastuzumab Deruxtecan for Treating HER2-Positive Unresectable or Metastatic Breast Cancer After Two or More Anti-HER2 Therapies: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - Open. 7(3). 345–358. 2 indexed citations

Bresnahan, Rebecca, Rachel Houten, J Greenhalgh, et al.. (2023). Pegcetacoplan for Treating Paroxysmal Nocturnal Haemoglobinuria: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - Open. 7(4). 525–536.

Chaplin, Marty, Rebecca Bresnahan, Nigel Fleeman, et al.. (2023). Onasemnogene Abeparvovec for Treating Pre-symptomatic Spinal Muscular Atrophy: An External Assessment Group Perspective of the Partial Review of NICE Highly Specialised Technology Evaluation 15. PharmacoEconomics - Open. 7(6). 863–875. 6 indexed citations

Bresnahan, Rebecca, Rui Duarte, James Mahon, et al.. (2023). Diagnostic accuracy and clinical impact of MRI-based technologies for patients with non-alcoholic fatty liver disease: systematic review and economic evaluation. Health Technology Assessment. 27(10). 1–115. 4 indexed citations

Mahon, James, Sophie Beale, Mick Arber, et al.. (2022). A systematic review of cost-utility analyses of screening methods in latent tuberculosis infection in high-risk populations. BMC Pulmonary Medicine. 22(1). 375–375. 12 indexed citations

Hounsome, Juliet, Gerlinde Pilkington, James Mahon, et al.. (2020). Prophylactic removal of impacted mandibular third molars: a systematic review and economic evaluation. Health Technology Assessment. 24(30). 1–116. 33 indexed citations

Mata‐Cases, Manel, James Mahon, Dı́dac Mauricio, et al.. (2020). Improving management of glycaemic control in people with T2DM in primary care: estimation of the impact on the clinical complications and associated costs. BMC Health Services Research. 20(1). 803–803. 6 indexed citations

10.

Duarte, Rui, Angela Stainthorpe, J Greenhalgh, et al.. (2019). The clinical and cost effectiveness of lead-I electrocardiogram (ECG) devices for detecting atrial fibrillation using single-time point testing in primary care: a systematic review and economic evaluation. Health Technology Assessment. 1 indexed citations

11.

Duarte, Rui, Angela Stainthorpe, James Mahon, et al.. (2019). Lead-I ECG for detecting atrial fibrillation in patients attending primary care with an irregular pulse using single-time point testing: A systematic review and economic evaluation. PLoS ONE. 14(12). e0226671–e0226671. 17 indexed citations

12.

Fleeman, Nigel, James Mahon, Sarah J Nevitt, et al.. (2019). Cenegermin for Treating Neurotrophic Keratitis: An Evidence Review Group Perspective of a NICE Single Technology Appraisal. PharmacoEconomics - Open. 3(4). 453–461. 22 indexed citations

13.

Mahon, James, Carlos H. Lifschitz, Thomas Ludwig, et al.. (2017). The costs of functional gastrointestinal disorders and related signs and symptoms in infants: a systematic literature review and cost calculation for England. BMJ Open. 7(11). e015594–e015594. 44 indexed citations

14.

Mahon, James, et al.. (2017). Misuse and/or treatment delivery failure of inhalers among patients with asthma or COPD: A review and recommendations for the conduct of future research. Respiratory Medicine. 129. 98–116. 33 indexed citations

15.

Glanville, Julie, Thomas Ludwig, Carlos H. Lifschitz, et al.. (2016). Costs associated with functional gastrointestinal disorders and related signs and symptoms in infants: a systematic review protocol. BMJ Open. 6(8). e011475–e011475. 9 indexed citations

16.

Mahon, James, Lindsay Claxton, & Hannah Wood. (2016). Modelling the cost-effectiveness of human milk and breastfeeding in preterm infants in the United Kingdom. Health Economics Review. 6(1). 54–54. 24 indexed citations

17.

Owens, Lynn, Ruwanthi Kolamunnage‐Dona, Alan Owens, et al.. (2016). A Randomized Controlled Trial of Extended Brief Intervention for Alcohol-Dependent Patients in an Acute Hospital Setting. Alcohol and Alcoholism. 51(5). 584–592. 2 indexed citations

18.

Craig, Joyce, James Mahon, Ann Yellowlees, et al.. (2014). Epithelium-Off Photochemical Corneal Collagen Cross-Linkage Using Riboflavin and Ultraviolet A for Keratoconus and Keratectasia: A Systematic Review and Meta-Analysis. The Ocular Surface. 12(3). 202–214. 29 indexed citations

19.

Hockenhull, Jo, Mary Gemma Cherry, James Mahon, et al.. (2012). A systematic review of the clinical effectiveness and cost-effectiveness of Pharmalgen® for the treatment of bee and wasp venom allergy.. Health Technology Assessment. 16(12). III–IV, 1. 54 indexed citations

20.

Edmonds, Michael, Michael Bauer, Sylvia L. Osborn, et al.. (1998). Using the vista 350 telephone to communicate the results of home monitoring of diabetes mellitus to a central database and to provide feedback. International Journal of Medical Informatics. 51(2-3). 117–125. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact